SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells
Cancers · 19.07.2023 · 15 (14) · 3671
DOI: 10.3390/cancers15143671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.07.2023. Verfasst von Roudy C Ekyalongo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, DOD BCRP award, Loyola University Chicago.
Abstract (Originalsprache)
SELENOF expression is significantly lower in aggressive breast tumors compared to normal tissue, indicating that its reduction or loss may drive breast tumorigenesis. Deletion of SELENOF in non-tumorigenic immortalized breast epithelial MCF-10A cells resulted in enhanced proliferation, both in adherent culture and matrix-assisted three-dimmensional (3D) growth. Modulation of SELENOF in vitro through deletion or overexpression corresponded to changes in the cell-cycle regulators p21 and p27, which is consistent with breast tumor expression data from the METABRIC patient database. Together, these findings indicate that SELENOF affects both proliferation and cell death in normal epithelial and breast cancer cells, largely through the regulation of p21 and p27. In glandular cancers like breast cancer, the filling of luminal space is one of the hallmarks of early tumorigenesis. Loss of SELENOF abrogated apoptosis and autophagy, which are required for the formation of hollow acini in MCF-10A cells in matrix-assisted 3D growth, resulting in luminal filling. Conversely, overexpression of SELENOF induced cell death via apoptosis and autophagy. In conclusion, these findings are consistent with the notion that SELENOF is a breast tumor suppressor, and its loss contributes to breast cancer etiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60153, USA.
ORCID-Profile: Kanishka Singh, Irida Kastrati
Förderung
- United States Department of Defense
- DOD BCRP award
- Loyola University Chicago
Zitieren
APA
Ekyalongo, R. C., Flowers, B., Sharma, T., Zigrossi, A., Zhang, A., Quintanilla-Arteaga, A., Singh, K., & Kastrati, I. (2023). SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells. Cancers, 15(14), 3671. https://doi.org/10.3390/cancers15143671
Vancouver
Ekyalongo RC, Flowers B, Sharma T, Zigrossi A, Zhang A, Quintanilla-Arteaga A, et al. SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells. Cancers. 2023;15(14):3671. doi:10.3390/cancers15143671
BibTeX
@article{Ekyalongo2023,
author = {Ekyalongo, Roudy C and Flowers, Brenna and Sharma, Tanu and Zigrossi, Alexandra and Zhang, An and Quintanilla-Arteaga, Anaisa and Singh, Kanishka and Kastrati, Irida},
title = {SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells},
journal = {Cancers},
year = {2023},
volume = {15},
number = {14},
pages = {3671},
doi = {10.3390/cancers15143671}
}
EUVIMED